These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 29203483)
1. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease. Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483 [TBL] [Abstract][Full Text] [Related]
2. Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease. Koh WJ; Jeong BH; Jeon K; Park HY; Kim SY; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL Antimicrob Agents Chemother; 2015 Aug; 59(8):4994-6. PubMed ID: 25987622 [TBL] [Abstract][Full Text] [Related]
3. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease. Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520 [TBL] [Abstract][Full Text] [Related]
4. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. Wallace RJ; Brown-Elliott BA; McNulty S; Philley JV; Killingley J; Wilson RW; York DS; Shepherd S; Griffith DE Chest; 2014 Aug; 146(2):276-282. PubMed ID: 24457542 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Mycobacterium avium Complex (MAC). Griffith DE Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550 [No Abstract] [Full Text] [Related]
6. Comparison of treatment outcomes between intermittent and daily regimens in non-cavitary nodular bronchiectatic-type Jung J; Chong YP; Lee HJ; Shim TS; Jo K-W Antimicrob Agents Chemother; 2023 Nov; 67(11):e0100323. PubMed ID: 37843254 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease. Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N; J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726 [TBL] [Abstract][Full Text] [Related]
8. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease. Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of Koh WJ; Moon SM; Kim SY; Woo MA; Kim S; Jhun BW; Park HY; Jeon K; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Kim H; Kwon OJ Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28954780 [TBL] [Abstract][Full Text] [Related]
10. Redevelopment after spontaneous sputum conversion in noncavitary nodular bronchiectatic Mycobacterium avium complex lung disease. Kim OH; Chong YP; Shim TS; Jo KW J Infect Chemother; 2021 Aug; 27(8):1156-1161. PubMed ID: 33745810 [TBL] [Abstract][Full Text] [Related]
11. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease. Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950 [TBL] [Abstract][Full Text] [Related]
12. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease. Jeong BH; Jeon K; Park HY; Moon SM; Kim SY; Lee SY; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2016 Oct; 60(10):6076-83. PubMed ID: 27480854 [TBL] [Abstract][Full Text] [Related]
13. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease. Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy. Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483 [TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease. Chae G; Park YE; Chong YP; Lee HJ; Shim TS; Jo KW Antimicrob Agents Chemother; 2022 Sep; 66(9):e0226121. PubMed ID: 35950842 [TBL] [Abstract][Full Text] [Related]
16. Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression. Pan SW; Shu CC; Feng JY; Wang JY; Chan YJ; Yu CJ; Su WJ Clin Infect Dis; 2017 Sep; 65(6):927-934. PubMed ID: 28541556 [TBL] [Abstract][Full Text] [Related]
17. Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend. Griffith DE; Aksamit TR Chest; 2021 Apr; 159(4):1372-1381. PubMed ID: 33080299 [TBL] [Abstract][Full Text] [Related]
18. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Ye JJ; Wu TS; Chiang PC; Lee MH J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469 [TBL] [Abstract][Full Text] [Related]
19. Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease. Moon SM; Yoo IY; Huh HJ; Lee NY; Jhun BW Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611366 [TBL] [Abstract][Full Text] [Related]